A transactivation-deficient mouse model provides insights into Trp53 regulation and function

Area of Science:

• Molecular Biology
• Cancer Research
• Genetics

Background:

• The tumor suppressor gene Trp53 (p53) is frequently mutated in human cancers.
• The precise mechanisms underlying Trp53's tumor-suppressive functions are not fully understood.
• Key functional domains, including the transactivation domain, are critical for p53 activity.

Purpose of the Study:

• To investigate the in vivo role of the Trp53 transactivation domain in tumor suppression.
• To analyze the structural and functional consequences of mutations within the Trp53 transactivation domain.
• To elucidate the specific pathways regulated by the Trp53 transactivation domain.

Main Methods:

• Generation of mice with a Trp53 allele encoding specific mutations (Leu25, Trp26) in the transactivation domain.
• Analysis of mutant Trp53 protein stability, DNA binding, and interaction with Mdm2.
• Assessment of cell-cycle regulation and apoptosis in mutant Trp53 mouse embryonic fibroblasts (MEFs).
• Evaluation of oncogene-induced transformation and tumor development in mice carrying the mutant Trp53 allele.

Main Results:

• Mutant Trp53 protein was abundant and constitutively bound DNA, independent of DNA damage.
• Despite normal DNA binding, mutant Trp53 exhibited defects in cell-cycle regulation and apoptosis.
• Both mutant Trp53 and Trp53-null MEFs were susceptible to oncogene-induced transformation.
• Mice with the mutant Trp53 allele displayed increased susceptibility to tumor development.

Conclusions:

• The transactivation domain is essential for the tumor-suppressor function of Trp53 in mice.
• Mutations affecting the transactivation domain impair critical p53 functions, leading to oncogenic transformation and tumorigenesis.
• These findings highlight the indispensable role of Trp53's transcriptional activity in preventing cancer.